.

ISSN 2063-5346
For urgent queries please contact : +918130348310

DEMENTIA DISEASE THERAPIES USING EMF ANTENNA EXPOSURE ON A MULTILAYER HUMAN HEAD SIMULATION

Main Article Content

Mr. Harshal Ratan Shelar, Dr. Nitin S. Patil, Mr. Rakesh Kumar Jha
» doi: 10.31838/ecb/2023.12.s3.137

Abstract

In this study, we extend previous biological research that shown that repeated electromagnetic field stimulation (REMFS) reduced levels of toxic amyloid-beta (A), which is thought to be the root cause of Alzheimer's disease (AD). In primary human neural cultures, the REMFS values for these exposures were a frequency of 64 MHz and a Specific absorption rate (SAR) of 0.4 to 0.9 W/Kg. The high-frequency simulation system (HFSS/EMPro) software was used in this study to simulate an electromagnetic field (EMF) model. In order to reduce the harmful A levels in our biological investigations in a model of a human skull, we set out to obtain the EM parameters (EMF Frequency and SAR). The simulations carried out here may successfully guide the creation of an exposure system to treat Alzheimer's sufferers. The study took into account a well-known VFH (very high frequency) patch microstrip antenna technology. The decision was made based on the construction's ease of use and suitability for VHF applications. Using a model of a human head, the evaluation of the SAR and temperature distribution on the several head layers—including the skin, fat, dura, cerebrospinal fluid (CSF), grey matter, and brain tissues—was done to determine the effectiveness of the SAR and the safety of temperature rise. Maximum SAR of 0.6 W/Kg was attained using a current pulse of 1 A peak current delivered to the antenna feeder. The layers of the simulated human skull were found to have a range of 0.4 to 0.6 SAR. The antenna's first design suggested a dimension of around 1 m in length and breadth, indicating a stationary useful model for AD treatment. Future directions are provided for exposure systems and wearable antennas that are very effective and comfortable for patients.

Article Details